Literature DB >> 10984672

Diagnosis and treatment of 6-pyruvoyl-tetrahydropterin synthase deficiency.

H Shintaku1, M Asada, Y Sawada.   

Abstract

We detected a case of 6-pyruvoyl tetrahydropterin synthase (PTPS) deficiency during a neonatal mass screening and considered the differentiation and treatment of the peripheral form of PTPS deficiency. Although single treatment of BH4 had been started, because of the lowered biopterin (B) value, elevated neopterin (N) value, and N/B ratio in the cerebrospinal fluid (CSF), the peripheral form was judged negative and combined treatment with L-dopa and 5-hydroxy tryptophan (5-HTP) was started. Follow-up study will be necessary to confirm the diagnosis of PTPS deficiency.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10984672     DOI: 10.1016/s0387-7604(00)00132-7

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  2 in total

1.  Treatment and outcome of Taiwanese patients with 6-pyruvoyltetrahydropterin synthase gene mutations.

Authors:  Y H Chien; S C Chiang; A Huang; J M Lin; Y N Chiu; S P Chou; S Y Chu; T R Wang; W L Hwu
Journal:  J Inherit Metab Dis       Date:  2001-12       Impact factor: 4.982

2.  Cranial MR spectroscopy of tetrahydrobiopterin deficiency.

Authors:  Yin-Hsiu Chien; Shiin-Feng Peng; Tso-Ren Wang; Wuh-Liang Hwu
Journal:  AJNR Am J Neuroradiol       Date:  2002 Jun-Jul       Impact factor: 3.825

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.